Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Aug 06, 2026 >>   ABB 7722 [ 0.10 ]ACC 1378.75 [ -1.01 ]AMBUJA CEM 436.5 [ -1.47 ]ASIAN PAINTS 2749 [ -0.26 ]AXIS BANK 1253 [ -0.71 ]BAJAJ AUTO 11586.2 [ -0.82 ]BANKOFBARODA 250 [ 1.75 ]BHARTI AIRTE 1964 [ 0.10 ]BHEL 411 [ 0.15 ]BPCL 325.4 [ 0.11 ]BRITANIAINDS 5430 [ -0.26 ]CIPLA 1475 [ 1.72 ]COAL INDIA 412.7 [ -0.31 ]COLGATEPALMO 2031.2 [ -0.02 ]DABUR INDIA 414 [ 0.00 ]DLF 642.9 [ -3.18 ]DRREDDYSLAB 1175 [ 0.09 ]GAIL 176 [ 0.57 ]GRASIM INDS 3207.8 [ 0.31 ]HCLTECHNOLOG 1341 [ 0.00 ]HDFC BANK 737 [ 0.00 ]HEROMOTOCORP 5621 [ -0.69 ]HIND.UNILEV 2085 [ 0.29 ]HINDALCO 1026.55 [ -1.20 ]ICICI BANK 1476.95 [ 2.28 ]INDIANHOTELS 736.9 [ 0.22 ]INDUSINDBANK 1006 [ -1.08 ]INFOSYS 1165.2 [ -0.83 ]ITC LTD 285 [ 0.00 ]JINDALSTLPOW 1100 [ -1.68 ]KOTAK BANK 394 [ -1.01 ]L&T 4050 [ 0.05 ]LUPIN 2391.5 [ 0.23 ]MAH&MAH 3415 [ -1.41 ]MARUTI SUZUK 13997 [ -1.15 ]MTNL 27.7 [ 0.14 ]NESTLE 1500 [ -1.38 ]NIIT 98.11 [ -0.68 ]NMDC 85.75 [ 0.40 ]NTPC 344 [ -1.15 ]ONGC 237.8 [ -0.67 ]PNB 114 [ 0.40 ]POWER GRID 270.75 [ -3.99 ]RIL 1325 [ 3.43 ]SBI 1084.85 [ 3.02 ]SESA GOA 274.6 [ -0.53 ]SHIPPINGCORP 308.45 [ 2.59 ]SUNPHRMINDS 1944 [ -0.26 ]TATA CHEM 663.25 [ -0.38 ]TATA GLOBAL 1090 [ 0.30 ]TATA MOTORS 343.75 [ -0.94 ]TATA STEEL 189.3 [ -1.02 ]TATAPOWERCOM 381 [ 0.26 ]TCS 2370 [ -2.06 ]TECH MAHINDR 1635 [ -0.91 ]ULTRATECHCEM 12062 [ -1.12 ]UNITED SPIRI 1516 [ -0.59 ]WIPRO 185.9 [ -0.08 ]ZEETELEFILMS 92.5 [ -2.06 ] BSE NSE
You can view the entire text of Notes to accounts of the company for the latest year

BSE: 524558ISIN: INE794A01010INDUSTRY: Pharmaceuticals

BSE   ` 21499.95   Open: 21270.10   Today's Range 20972.65
22499.70
+1535.25 (+ 7.14 %) Prev Close: 19964.70 52 Week Range 11500.00
22499.70
Year End :2026-03 

r. Provisions, contingent liabilities and
contingent assets

Provisions are recognized only when there
is a present obligation, as a result of past
events, and when a reliable estimate of the
amount of obligation can be made at the
reporting date. These estimates are reviewed
at each reporting date and adjusted to reflect
the current best estimates. Provisions are
discounted to their present values, where the
time value of money is material.

Contingent liability is disclosed for:

• Possible obligations which will be
confirmed only by future events
not wholly within the control of the
Company; or

• Present obligations arising from past
events where it is not probable that an
outflow of resources will be required to
settle the obligation or a reliable estimate
of the amount of the obligation cannot
be made.

Contingent assets are neither recognized
nor disclosed. However, when realization
of income is virtually certain, related asset
is recognized.

s. Exceptional items

Exceptional items are transactions which
due to their size or incidence are separately
disclosed to enable a full understanding of
the Company's financial performance. Items
which may be considered exceptional are

significant restructuring charges, gains
or losses on disposal of investments in
subsidiaries, impairment losses/write down in
value of investment in subsidiaries, significant
disposal of property, plant and equipment,
investment property etc.

(iii) Standards (including amendments) issued but not
yet effective

Amendment to Ind AS 1 'Presentation of Financial
Statements'- Classification of Liabilities as current or
non-current and non-current liabilities with covenants:

The amendment includes specific provisions that will
take effect for reporting periods beginning on or after
1 April 2026, retrospectively, as outlined below:

a) Breach of material covenant for long-term loan
arrangement on or before end of reporting period
with effect that liability becomes payable on
demand as on reporting date, then it shall be
classified as current liability, if lender agreed
after reporting period and before approval of
financial statements to not demand payment as a
consequence of breach.

b) Classify as non-current liability, if lender agreed
by end of reporting period to provide grace period
ending at least 12 months after reporting period
within which entity can rectify the breach provided
lender does not demand immediate repayment.

c) Disclose information about the timing of settlement
to understand the impact of the liability on the
financial statements.

The Company does not expect this amendment to have
an impact on its operations or financial statements.

1 Project execution plans are reviewed periodically on the basis of management judgement and estimates w.r.t future
technology and development/economy/industry/regulatory environment and all the projects are assessed as per periodic
plans.

2 During the year the Company has capitalised interest costs on specified borrowings amounting to ? 148.93 (March 31,
2025: ? Nil) with the effective interest rate for capitalisation was approx 7.3% (March 31,2025: Nil).

3 Contractual Obligation: Refer Note 39 for details of contractual Commitments for acquiring Property, plant and equipment.

Investments in JETL and PETL are in the nature of investments in equity instruments which are not held for trading. Instead,
they are held for long term strategic purpose. Upon the application of Ind AS 109, the Company has chosen to designate
these investments in equity instruments at fair value through other comprehensive income ('FVTOCI'), irrevocably, as the
Management believes that this provides a more meaningful presentation for long term strategic investments, than reflecting
changes in fair value immediately in profit or loss.

The investment was recognised initially at transaction cost and irrevocably designated at FVTOCI.

Refer Note 31 for fair value measurement and Note 32 for information about the company's exposure to financial risks.

ii. Rights, preferences and restrictions attached to equity shares:

The Company declares and pays dividends in Indian rupees. The dividend proposed by the Board of Directors is subject
to approval of shareholders in the ensuing Annual General Meeting, except in case of interim dividend. In the event of
liquidation of the Company, the holders of equity shares will be entitled to receive the remaining assets of the Company,
after distribution of all preferential amounts in proportion of their shareholding. The Company has only one class of
equity shares having a par value of ?10 per share. Each holder of equity shares is entitled to one vote per share.

(b) The above loans are secured by pari-passu first charge on property, plant and equipment (both present and future)
and second charge (hypothecation) on the current assets of the Company.

(c) Vehicles loans outstanding to the tune of ? 609.67 (March 31, 2025: ? ? 527.71) are secured by hypothecation of
specific vehicles against which the loan was availed. These vehicle loans are repayable in instalments in 48 months
from the date of the loan.

(d) All the above loans carry interest in the range of 1.8% to 8.9% per annum as at March 31, 2026 (March 31, 2025:
1.8% to 9.0% per annum) being floating and fixed rate.

(e) The Company has utilised the Borrowings for the pupose for which it has obtained as mentioned in the
respective agreements.

(f) Refer Note 32 for the Maturity profile of borrowings including current maturities.

(g) Refer Note 31 for fair value measurement.

Gratuity

The Company has a defined benefit funded gratuity plan and it operates through Neuland Laboratories Limited employee
group gratuity trust ("the Trust") except for contract workman engaged through contractors. Every employee who has
completed service of five years or more and one year or more in case of fixed term employees gets a gratuity on departure
at 15 days wages (as defined as per New Labour Code) for each completed year of service. The Company has subscribed
to a group gratuity scheme of Life Insurance Corporation of India (LIC) and SBI Life and contributes the gratuity liability to
the Trust. Under the said policy, the eligible employees are entitled for gratuity upon their resignation or in the event of
death in lumpsum after deduction of necessary taxes up to a maximum limit of ?20.

The following table set out the status of the gratuity plan and the reconciliation of opening and closing balances of the
present value and defined benefit obligation.

Notes:

(i) The Company has access to financing facilities in the form of Letter of Credit / Bank Guarantee / Buyers Credit / Cash
Credit facilities of ? 60,000.00 out of which ? 26,662.55 were not used (March 31, 2025 : ? 35,140.00 out of which
? 30,082.26 were not used) at the end of the reporting period.

(ii) The loans with all working capital lenders are secured by way of pari-passu first charge on all the current assets of the
Company and pari-passu second charge on Company's property, plant and equipment.

(iii) The quarterly returns/statements submitted with banks are in agreement with the books of accounts.

Performance Obligation:

Sale of products: Performance obligation in respect of sale of goods is satisfied when control of the goods is transferred to
the customer, generally on delivery of the goods and payment is generally due as per the terms of contract with customers.

Sale of services: The performance obligation in respect of maintenance services is satisfied over a period of time and
acceptance of the customer. In respect of these services, payment is generally due upon completion of maintenance period
based on time elapsed and acceptance of the customer. In certain non-standard contracts, where the Company provides
warranties in service of consumer durable goods, the same is accounted for as a separate performance obligation and
a portion of the transaction price is allocated based on its relative standalone prices. The performance obligation for the
warranty service is satisfied over a period of time based on time elapsed.

Remaining performance obligations

The aggregate value of transaction price allocated to unsatisfied (or partially satisfied) performance obligations in case of
contracts for which revenues are recorded over a period of time is ?232.20 (March 31,2025: ?211.36), which is expected
to be fully recognised as revenue in the next year. No consideration from contracts with customers is excluded from the
amount mentioned above and contract asset relating to partially satisfied performance obligations aggregates to ?117.28
as at March 31, 2026 (March 31, 2025: ?49.83)

(i) Details of CSR expenditure :

As per Section 135 of the Companies Act, 2013, the required CSR expenditure for the year ended March 31,2026 was
? 608.99 (March 31,2025: ? 491.52). During the year, amounts were primarily utilised towards promoting education,
skill development, women's empowerment, health and well-being, clean water and sanitation, development of village
infrastructure, and environmental sustainability.

31. FAIR VALUE MEASUREMENTS
(i) Fair value hierarchy

Financial assets and financial liabilities measured at fair value in the Balance Sheet are grouped into three levels of a
fair value hierarchy. The three levels are defined based on the observability of significant inputs to the measurement,
as follows:

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: The fair value of financial instruments that are not traded in an active market is determined using valuation
techniques which maximise the use of observable market data either directly or indirectly.

Level 3: If one or more of the significant inputs is not based on observable market data, the instrument is included in
level 3.

32. FINANCIAL INSTRUMENTS RISK MANAGEMENT

The Company is exposed to various financial risks arising from its operations and the use of financial instruments.
The key financial risks include market risk, credit risk and liquidity risk. The Company's risk management policies are
established to identify and analyse the risks faced by the Company and seek to, where appropriate, minimize potential
impact of the risk and to control and monitor such risks. The Company's risk management is coordinated by the Board
of Directors and focuses on securing long term and short term cash flows. The Company does not engage in trading
of financial assets for speculative purposes.

The following sections provide details regarding the Company's exposure to the financial risks associated with financial
instruments held in the ordinary course of business and the objectives, policies and processes for management of
these risks.

A. Market risk:

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of
changes in market prices. Market risk comprises two types of risk: interest rate risk and currency risk. Financial
instruments affected by market risk include borrowings, deposits, trade receivables and other financial instruments.

The sensitivity analyses in the following sections relate to the position as at March 31,2026 and March 31,2025.
The analysis exclude the impact of movements in market variables on the carrying values of gratuity and other
post retirement obligations; provisions; and non-financial assets and liabilities.

i. Interest rate risk:

I nterest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate
because of changes in market interest rates. The Company has loan facilities on floating interest rate, which
exposes the Company to risk of changes in interest rates. The management monitors the interest rate
movement and manages the interest rate risk based on its policies, which include entering into interest rate
swaps as considered necessary. The Company's investment in deposits with banks are for short durations
and therefore do not expose the Company to significant interest rate risk. Below are the details of exposure
to fixed rate and variable rate instruments:

The Company's principal financial liabilities comprise borrowings, lease liabilities, trade and other payables. The main
purpose of these financial liabilities is to finance the Company's operations. The Company's principal financial assets
comprise of investments, trade and other receivables, cash and cash equivalents and other bank balances derived
directly from its operations.

(iv) The carrying amounts of trade receivables, trade payables and cash and cash equivalents are considered to be the same as
their fair values, due to their short-term nature. Difference between carrying amounts and fair values of bank deposits, other
financial assets, other financial liabilities and borrowings subsequently measured at amortised cost is not significant in each
of the years presented. For all other amortised cost instruments, carrying value represents the best estimate of fair value.
For financial assets measured at fair values, the carrying amounts are equal to the fair values.

Every 0.5% increase/decrease in the interest rate component applicable to the respective borrowings would
effect the Company's net profit before tax resulting in an expense/income of ?89.78 and ?55.51 for the year
ended March 31,2026 and March 31, 2025 respectively.

ii. Foreign currency risk:

Foreign currency risk is the risk that the value of a financial instrument will fluctuate due to changes in
foreign exchange rates. The Company's exposure to the risk of change in foreign exchange rates relates
primarily to the Company's operating activities (when revenue or expense is denominated in foreign currency)
and financing activities (when borrowings are denominated in foreign currency), The foreign currencies in
which these transactions are denominated are US Dollars, Euros, Japanese Yen, Great British Pound and
Swiss Franc.

B. Credit risk

Credit risk is the risk that a counterparty fails to discharge an obligation to the Company, leading to a financial loss.
The Company is mainly exposed to the risk of its balances with the bankers and trade and other receivables. None
of the Company's cash equivalents, other bank balances, loans and security deposits were past due or impaired
as at March 31, 2026 and March 31, 2025.

C. Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due.
The Company manages its liquidity risk by ensuring, as far as possible, that it will always have sufficient liquidity
to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses
or risk to the Company's reputation.

Management monitors rolling forecasts of the Company's liquidity position (comprising the undrawn borrowing
facilities) and cash and cash equivalents on the basis of expected cash flows.

Maturities of financial liabilities

The tables below analyse the Company's financial liabilities into relevant maturity groupings based on their
contractual maturities for all non-derivative financial liabilities. The amounts disclosed in the table are the
contractual undiscounted cash flows:

33. CAPITAL RISK MANAGEMENT

The Company's objective when managing capital is to safeguard the Company's ability to continue as a going concern
in order to provide returns for shareholders and benefits for stakeholders and to maintain an optimal capital structure
to reduce the cost of capital. Hence, the Company may adjust any dividend payments, return capital to shareholders
or issue new shares or sell assets to reduce debt. Total capital is the equity as shown in the statement of financial
position. Currently, the Company primarily monitors its capital structure on the basis of the following gearing ratio.
Management is continuously evolving strategies to optimize the returns and reduce the risks. It includes plans to
optimize the financial leverage of the Company.

36(b) During the previous year, the Company has fully transferred an investment property located in Nanakramguda,
Hyderabad, Telangana, through perpetual lease, resulting in total profit of ? 7,640.36 lakhs being the profit is
exceptional in nature, it has been disclosed as a separate line item.

37. GOODWILL

Pursuant to the Scheme of Amalgamation and Arrangement ("the Scheme") duly approved by the National Company
Law Tribunal, Hyderabad Bench vide their order dated March 21, 2018, Neuland Health Sciences Private Limited
("NHSPL") and Neuland Pharma Research Private Limited ("NPRPL") (together referred to as "Transferor Companies"),
were merged with the Company with appointed date of April 01,2016. NHSPL is engaged in the business of conducting
research and development of Peptides and NPRPL is in the business of contract research services.

The purchase consideration of ?31,084.99 paid by way of issue of 22,70,635 equity shares of ?10 each [in accordance
with the Scheme, 45,90,608 equity shares of ?10 each held by NHSPL in the Company stands cancelled and the
Company has issued 68,61,095 and 148 fully paid-up equity shares of ?10 each to the shareholders of NHSPL and
NPRPL respectively] at a premium of ?1,359 per equity share.

(d) Remuneration to KMP excludes contribution for gratuity and compensated absences as the increment liability has been
accounted for the Company as a whole.

(e) Transaction with related parties

In accordance with the applicable provisions of the Income Tax Act, 1961, the Company is required to use certain
specified methods in assessing that the transactions with the subsidiaries, are carried at an arm's length price and is
also required to maintain prescribed information and documents to support such assessment. The appropriate method
to be adopted will depend on the nature of transactions / class of transactions, class of associated persons, functions
performed and other factors as prescribed. Based on certain internal analysis carried out, management believes that
transactions entered into with the related parties were carried out at arms length prices.

39. COMMITMENTS

Estimated amount of contracts remaining to be executed on capital account and not provided for (net of advances)
amounts to ?15,418.48 (March 31, 2025: ?8,325.51).

Notes:

Other Disputes/Matters:

(a) Our Company purchased land in Survey No. 490/2 situated at Bonthapally Village, Jinnaram Mandal, Medak District.
The Revenue department issued notices to our Company for resumption of the said land on the ground that the same
was "assigned land". Our Company has filed an application before the Collector, Medak District for regularization
of the said land as per the applicable laws. Our Company also filed a writ petition before the High Court praying
for an order not to take any coercive steps. The High Court vide its order dated March 18, 2011 directed the
revenue department to not take any coercive steps till the disposal of the representation filed by our Company.
The matter is pending before the Collector, Medak District. The management believes that the outcome will be in favour
of the Company and hence no adjustment is made in the financial statements.

(b) During the financial year ended March 31,2008, the Commissioner and Inspector General of Stamps and Registration
(CIGSR), Andhra Pradesh has vide it's order dated February 22, 2008 has cancelled the registration of the land parcel
owned by the Company situated at Bonthapally pursuant to complaint made by one of the seller. Aggrieved by the
aforesaid order the Company has filed a writ petition challenging order of CIGSR with Hon'ble High Court of Telangana
(the 'Court') as the Company was not involved during the proceedings. The Court has vide its order dated December
31, 2010 has directed to maintain the status quo with regards to the possession of the property till further orders
passed. Proceedings of the case are still pending with the court. The management is confident that orders will be in
the favour of the Company, hence no adjustment is deemed necessary to these standalone financial statements.

(c) The Company received demand notices from the electricity authority (TSSPDCL) for amounts related to surplus power
adjustments between 2005 and 2007. Following a High Court ruling that allowed revised billing, the authority demanded
both principal amount and surcharge (interest).

The Company has already paid the principal amount under protest. Based on legal advice, management believes no
additional liability (particularly for surcharge) will arise.

Notes:

1. The aggregate depreciation expense on right-of-use assets of ? 1,002.40 (March 31,2025: ? 491.56) is included
under depreciation and amortization expense in the Statement of Profit and Loss.

2. Rental expense recorded for short-term and low value leases was ? 98.56 (March 31,2025: ? 77.84) for the year
ended March 31, 2026 (Refer Note 28).

3. The Company does not face a significant liquidity risk with regard to its lease liabilities as the current assets are
sufficient to meet the obligations related to lease liabilities as and when they fall due.

44. SEGMENT REPORTING

In accordance with Ind AS 108 - 'Operating segments', segment information has been given in the consolidated financial
statements of the Company and therefore no separate disclosure on segment information is given in these standalone
financial statements.

45. On November 21, 2025, the Government of India notified the four Labour Codes - the Code on Wages, 2019, the
Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working
Conditions Code, 2020 - consolidating 29 existing labour laws. The Ministry of Labour & Employment published draft
Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. The Company
has considered the impact of the changes, consistent with the Labour Codes, draft rules, FAQs and legal opinion.
The Company continues to monitor the finalisation of Central / State Rules and clarifications from the Government on
other aspects of the Labour Code and would provide appropriate accounting effect on the basis of such developments
as needed.

46. The Company has a process whereby periodically all long term contracts (including derivative contracts) are assessed
for material foreseeable losses. At the year end, the Company did not have any long-term contracts (including derivative
contracts) for which there were any material foreseeable losses.

47. OTHER STATUTORY INFORMATION:

i The Company does not have any Benami property, where any proceeding has been initiated or pending against
the company for holding any Benami property.

i i The Company has not been declared wilful defaulter by any bank or financial institution or government or any

government authority.

iii The Company does not have any transactions with companies struck off under section 248 of the Act or section
560 of Companies Act, 1956.

iv The Company does not have any charges or satisfaction which is yet to be registered with Registrar of Companies
beyond the statutory period.

v The Company has complied with the number of layers prescribed under clause (87) of section 2 of the Act read
with the Companies (Restriction on number of Layers) Rules, 2017.

vi The Company has not entered into any scheme of arrangement which has an accounting impact on current or
previous financial year.

vii No funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other
sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities
("Intermediaries”) with the understanding, whether recorded in writing or otherwise, that the Intermediary shall
lend or invest in party identified by or on behalf of the Company (Ultimate Beneficiaries).

viii The Company has not received any fund from any party(s) (Funding Party) with the understanding that the
Company shall whether, directly or indirectly lend or invest in other persons or entities identified by or on
behalf of the Company ("Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the
Ultimate Beneficiaries.

ix The Company does not have any undisclosed income which is not recorded in the books of account that has been
surrendered or disclosed as income during the year (and previous year) in the tax assessments under the Income
Tax Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act, 1961).

x The Company has not traded or invested in crypto currency or virtual currency during the current or previous year.

xi The Company has not revalued its property, plant and equipment (including right-of-use assets) and intangible
assets during the current year and previous year.

48. The standalone financial statements are approved for issue by the Company's Board of Directors on May 12, 2026.